Jason Hong is a Respiratory physician. ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Ucla Medical Plz Ste 365-B
Los Angeles, CA 900958344
Telephone
310-825-8061Registry record last updated 14 Nov 2019.
Clinical trials
- CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12
Sponsor: RAI Services Company
- CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12
Sponsor: RAI Services Company
- CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
Sponsor: RAI Services Company
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20252 payments
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
- Actelion Pharmaceuticals US, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.7%Soluble Guanylate Cyclase Stimulator14.8%Adempas100%Part D<11 patientsEndothelin Receptor Antagonist14.2%Ambrisentan100%Part D<11 patients+ 1 more class in this area
Blood & clotting
35.2%Prostacycline Vasodilator35.2%Tyvaso Dpi74%Orenitram Er26%Part D<11 patientsGenitourinary & hormones
19.1%Phosphodiesterase 5 Inhibitor19.1%Tadalafil58%Sildenafil Citrate42%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Asporin as a dual-pathway therapeutic target and biomarker for pulmonary arterial hypertension
University of California Los Angeles
FY2026$723,400R01HL183171 - Integrative Multiomics to Uncover Novel Genes and Networks in Pulmonary Arterial Hypertension
University of California Los Angeles
FY2026$176,580K08HL169982 - Integrative Multiomics to Uncover Novel Genes and Networks in Pulmonary Arterial Hypertension
University of California Los Angeles
FY2025$176,580K08HL169982
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”